Who Should Consider GLP-1 Therapy FDA indications for weight loss require: BMI 30 (obesity), or BMI 27 (overweight) with at least one weight-related condition hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or similar These thresholds set eligibility, but they don't answer the more important question: who benefits most
specific batch-level origin not published publicly), and the brand-stated review count of 9,000+ five-star reviews (brand-reported
J Cardiopulm Rehabil Prev
Lean Muscle Preservation Unlike generalized weight loss methods, this therapy helps you lose fat without sacrificing your lean muscle mass
Wells Fargo has yet to respond to these allegations
Clinical studies also show improved glucose regulation, which is beneficial for patients with diabetes, insulin resistance, or borderline blood sugar levels